Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostamatinib in Advanced Solid Tumors
NCT00923481Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2009
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fostamatinib in colorectal cancer (CRC), non-small cell lung cancer (NSCLC), head and neck cancer (HNC), hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Apr 2009; status: completed.
02
Drugs
fostamatinib
03
Conditions
colorectal cancer (CRC)non-small cell lung cancer (NSCLC)head and neck cancer (HNC)hepatocellular carcinoma (HCC)renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00923481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923481.